NEW YORK, Jan. 02, 2019 (GLOBE NEWSWIRE) — Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), an oncology company developing innovative medicines and imaging […]
— Agreement provides Sarepta with committed capacity and dedicated manufacturing slots for GMP-grade plasmid production for its micro-dystrophin Duchenne muscular […]
PLANO, Texas, Jan. 02, 2019 (GLOBE NEWSWIRE) — Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that […]